Results 31 to 40 of about 6,088,596 (303)

Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management

Biological Research, 2018
Minimal residual disease is that not detected by conventional imaging studies and clinically the patient remains disease free. However, with time these dormant cells will awaken and disease progression occurs, resulting in clinically and radiological ...
Nigel P. Murray
doaj   +1 more source

Zwitterionic microgel preservation platform for circulating tumor cells in whole blood specimen

Nature Communications, 2023
The immediate processing of whole blood specimen is required in circulating tumor cell-based liquid biopsy. Reliable blood specimen stabilization towards preserving circulating tumor cells can enable more extensive geographic sharing for precise rare ...
Yiming Ma, Jun Zhang, Yunqing Tian, Yihao Fu, Shu Tian, Qingsi Li, Jing Yang, Lei Zhang   +7 more
doaj   +1 more source

Isolation of circulating tumor cells

iScience, 2022
Circulating tumor cells (CTCs) enter the vasculature from solid tumors and disseminate widely to initiate metastases. Mining the metastatic-enriched molecular signatures of CTCs before, during, and after treatment holds unique potential in personalized oncology.
Jon F. Edd, Avanish Mishra, Kyle C. Smith, Ravi Kapur, Shyamala Maheswaran, Daniel A. Haber, Mehmet Toner   +6 more
openaire   +3 more sources

Using single-cell sequencing technology to detect circulating tumor cells in solid tumors

Molecular Cancer, 2021
Circulating tumor cells are tumor cells with high vitality and high metastatic potential that invade and shed into the peripheral blood from primary solid tumors or metastatic foci.
Jiasheng Xu, Kaili Liao, Xi Yang, Chengfeng Wu, Wei Wu, Shuwen Han   +5 more
doaj   +1 more source

Circulating circRNA: a social butterfly in tumors

Frontiers in Oncology, 2023
Circular RNAs (circRNAs) are a class of single-stranded non-coding RNAs that form circular structures through irregular splicing or post-splicing events.
Shuo Miao, Shuo Miao, Qingsong Zhang
doaj   +1 more source

Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma

Technology in Cancer Research & Treatment, 2020
Objective: Nasopharyngeal carcinoma is highly endemic in Southeast China. Circulating tumor cell is an important biomarker in the prognosis of variety kinds of cancers. Overexpression of fibronectin 1 was observed in variety kinds of malignancies and may
Ying Yu BM, Zhi-Xiu Lin BM, Hai-Wen Li MM, Hai-Qing Luo MD, Dong-Hong Yang MM, He-Chao Zhou MM, Dan-Xian Jiang MD, De-Chao Zhan MM, Liu Yang MM, Xiao-Ye Liang MM, Zhong-Hua Yu MM, Zi-Hong Chen BM   +11 more
doaj   +1 more source

Liquid-based biomarkers in breast cancer: looking beyond the blood

Journal of Translational Medicine, 2023
In recent decades, using circulating tumor cell (CTC), circulating tumor DNA (ctDNA), circulating tumor RNA (ctRNA), exosomes and etc. as liquid biomarkers has received enormous attention in various tumors, including breast cancer (BC).
You Shuai, Zhonghua Ma, Jie Ju, Tong Wei, Songlin Gao, Yikun Kang, Zixuan Yang, Xue Wang, Jian Yue, Peng Yuan   +9 more
doaj   +1 more source

Plasma next generation sequencing and droplet digital PCR‐based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent‐line osimertinib

Thoracic Cancer, 2019
Background Gene mutation analysis from plasma circulating tumor DNA (ctDNA) can provide timely information regarding the mechanism of resistance that could translate to personalised treatment.
Pei N. Ding, Therese Becker, Victoria Bray, Wei Chua, Yafeng Ma, Bo Xu, David Lynch, Paul de Souza, Tara Roberts   +8 more
doaj   +1 more source

Circulating Tumor Cell Composition in Renal Cell Carcinoma. [PDF]

PLoS ONE, 2016
PURPOSE:Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a "liquid biopsy" in solid tumors. However, successful application in metastatic renal cell carcinoma (mRCC) has been very limited so
Ivonne Nel, Thomas C Gauler, Kira Bublitz, Lazaros Lazaridis, André Goergens, Bernd Giebel, Martin Schuler, Andreas-Claudius Hoffmann   +7 more
doaj   +1 more source

The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer

, 2023
Background: Circulating tumor cells are cancer cells which separate from the primary tumor and enter systemic circulation. In this study, it was aimed to examine the relationship between circulating tumor cells isolated and identified from the peripheral
Başbınar, Yasemin, Öztop, İlhan, Tarkan Ünek, Uysal, Tuğba, İbrahim Astarcıoğlu, Asim Leblebici, Ünek, İlkay Tuğba, Leblebici, Asım, Hülya Ellidokuz, İlhan Öztop, Tuğba Uysal, Anıl Aysal, Ellidokuz, Hülya, Ibrahim Astarcioglu, Astarcıoğlu, İbrahim, Sağol, Özgül, İlkay Tuğba Ünek, Aysal, ANIL, Anil Aysal, Ece Çakıroğlu, Asım Leblebici, Yaemin Baspinar, Caner Karaca, Yasemin Başbınar, Çakıroğlu, Ece, Karaca, Caner, Ece Cakiroglu, Özgül Sağol, Ünek, Tarkan   +28 more
core   +1 more source